What are the treatment options for Polycystic Ovary Syndrome (PCOS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Polycystic Ovary Syndrome (PCOS)

Lifestyle modifications should be the first-line treatment for PCOS, with specific interventions including a 500-750 kcal/day caloric deficit diet low in glycemic index, rich in fiber and omega-3 fatty acids, and at least 250 minutes of moderate-intensity physical activity per week. 1

Lifestyle Interventions

Dietary Recommendations

  • Implement a caloric deficit of 500-750 kcal/day 1
  • Focus on low glycemic index foods, high fiber, and omega-3 fatty acids 1, 2
  • Consider Mediterranean diet, anti-inflammatory foods, and antioxidant-rich options 2
  • Even modest weight loss of 5-10% can restore ovulation and improve fertility 1

Physical Activity Guidelines

  • Aim for at least 250 minutes of moderate-intensity physical activity per week 1
  • Include strength training 2-3 times weekly 1
  • Daily goal of 10,000 steps including 30 minutes of structured activity (approximately 3,000 steps) 3
  • Set realistic SMART goals with progressive 5% weekly increases in physical activity 3
  • Consider fitness tracking devices to monitor progress and minimize sedentary behavior 3

Behavioral Strategies

  • Implement self-monitoring techniques 3
  • Incorporate family support to improve outcomes 3
  • Use goal-setting, stimulus control, problem-solving, and relapse prevention strategies 3

Pharmacological Interventions

For Metabolic Abnormalities

  • Metformin:
    • First-line medication for PCOS with metabolic features 1
    • Starting dose: 500 mg/day with meals, gradually increasing to 1000-1500 mg/day in divided doses 1
    • Benefits: improved insulin resistance, regularized menstrual cycles, reduced cardiometabolic risks 1

For Menstrual Irregularity and Hyperandrogenism

  • Combined Oral Contraceptives (COCs):

    • First-line therapy for menstrual regulation and reducing hyperandrogenism 1
    • Provides endometrial protection 1
    • Note: Increases venous thromboembolism risk three to fourfold (up to 4 per 10,000 woman-years) 1
  • Oral Micronized Progesterone:

    • 200-300 mg daily for 12-14 days monthly 1
    • Provides endometrial protection and improves menstrual regularity 1
    • Better safety profile than synthetic progestins 1
  • Levonorgestrel-releasing Intrauterine Device (LNG-IUD):

    • First-line non-oral contraceptive option 1
    • Effective for endometrial protection and menstrual regulation 1
    • Minimal impact on metabolic parameters 1
  • Spironolactone:

    • 100 mg daily for hirsutism 1
    • Visible improvement typically takes 6 months 1

For Fertility

  • Clomiphene Citrate:
    • First-line medication for ovulation induction 1, 4
    • Start on approximately day 5 of the cycle 1, 4
    • 80% ovulation rate and 50% conception rate 1
    • Should not be used in patients with ovarian cysts (except PCOS), abnormal vaginal bleeding, or liver dysfunction 4
    • Monitor for visual symptoms (rare but serious side effect) 4
    • Risk of Ovarian Hyperstimulation Syndrome (OHSS) - monitor for abdominal pain, distention, nausea, vomiting 4
    • Not recommended for long-term cyclic therapy beyond six cycles (including three ovulatory cycles) 4

Monitoring and Follow-up

  • Regular consultations every 6 months to monitor:

    • Blood pressure
    • Lipid profile
    • Menstrual cycles
    • Weight changes
    • Metabolic parameters 1
  • Screen for gestational diabetes and pre-eclampsia during pregnancy 1

Red Flags Requiring Prompt Evaluation

  • Persistent abnormal uterine bleeding despite treatment
  • Signs of significant virilization
  • Rapid development of symptoms
  • Significant weight gain or worsening insulin resistance despite treatment 1

Special Considerations

  • Women with PCOS have higher prevalence of weight gain and obesity 3
  • Both lean and overweight women with PCOS may have insulin resistance, but obesity exacerbates this condition 1
  • Increased risk of eating disorders such as bulimic hyperphagia 1
  • Higher risk of pregnancy complications including gestational diabetes, preeclampsia, and preterm birth 1

By implementing these evidence-based interventions in a structured manner, PCOS symptoms can be effectively managed while reducing long-term health risks associated with the condition.

References

Guideline

Menstrual Cycle Abnormalities in PCOS

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.